June 30, 2026 · Form 4 insider transaction
BENTSUR RON bought 12,500 shares of Nuvectis Pharma, Inc. at $20.00 per share, a transaction worth $250.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Mr. Bentsur purchased 12,500 shares for $250,000 in the public offering announced on June 29, 2026.; Includes shares of restricted common stock.